[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Inomata et al., 2013 - Google Patents

Scaling of dorsal-ventral patterning by embryo size-dependent degradation of Spemann's organizer signals

Inomata et al., 2013

View HTML
Document ID
10421232812600057835
Author
Inomata H
Shibata T
Haraguchi T
Sasai Y
Publication year
Publication venue
Cell

External Links

Snippet

Spemann's organizer plays a key role in dorsal-ventral (DV) patterning in the amphibian embryo by secreting diffusible proteins such as Chordin, an antagonist to ventralizing bone morphogenetic proteins (BMPs). The DV patterning is so robust that an amphibian embryo …
Continue reading at www.cell.com (HTML) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G01N33/5023—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects on expression patterns
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/14—Type of nucleic acid interfering N.A.

Similar Documents

Publication Publication Date Title
Inomata et al. Scaling of dorsal-ventral patterning by embryo size-dependent degradation of Spemann’s organizer signals
Endoh-Yamagami et al. The mammalian Cos2 homolog Kif7 plays an essential role in modulating Hh signal transduction during development
Ataman et al. Nuclear trafficking of Drosophila Frizzled-2 during synapse development requires the PDZ protein dGRIP
Genevet et al. Kibra is a regulator of the Salvador/Warts/Hippo signaling network
Nedvetsky et al. Parasympathetic innervation regulates tubulogenesis in the developing salivary gland
Jeong et al. Growth and pattern of the mammalian neural tube are governed by partially overlapping feedback activities of the hedgehog antagonists patched 1 and Hhip1
Speese et al. Nuclear envelope budding enables large ribonucleoprotein particle export during synaptic Wnt signaling
Köppen et al. Coordinated cell-shape changes control epithelial movement in zebrafish and Drosophila
Raju et al. SANE, a novel LEM domain protein, regulates bone morphogenetic protein signaling through interaction with Smad1
Itasaki et al. Wise, a context-dependent activator and inhibitor of Wnt signalling
Scholpp et al. Endocytosis controls spreading and effective signaling range of Fgf8 protein
Jing et al. Wnt signals organize synaptic prepattern and axon guidance through the zebrafish unplugged/MuSK receptor
Yang et al. Basic fibroblast growth factor-induced neuronal differentiation of mouse bone marrow stromal cells requires FGFR-1, MAPK/ERK, and transcription factor AP-1
Tanimizu et al. α1-and α5-containing laminins regulate the development of bile ducts via β1 integrin signals
Maurya et al. Integration of Hedgehog and BMP signalling by the engrailed2a gene in the zebrafish myotome
Miller et al. Wnt ligands signal in a cooperative manner to promote foregut organogenesis
Van Boxtel et al. Long-range signaling activation and local inhibition separate the mesoderm and endoderm lineages
Caunt et al. Epidermal growth factor receptor and protein kinase C signaling to ERK2: spatiotemporal regulation of ERK2 by dual specificity phosphatases
Chai et al. MicroRNA-134 activity in somatostatin interneurons regulates H-Ras localization by repressing the palmitoylation enzyme, DHHC9
Baud’huin et al. A soluble bone morphogenetic protein type IA receptor increases bone mass and bone strength
Labalette et al. Hindbrain patterning requires fine-tuning of early krox20 transcription by Sprouty 4
Yu et al. The m6A readers YTHDF1 and YTHDF2 synergistically control cerebellar parallel fiber growth by regulating local translation of the key Wnt5a signaling components in axons
Schumacher et al. An intermediate level of BMP signaling directly specifies cranial neural crest progenitor cells in zebrafish
Coles et al. A vertebrate crossveinless 2 homologue modulates BMP activity and neural crest cell migration
Lodge et al. Tumor-derived MMPs regulate cachexia in a Drosophila cancer model